Maravai Lifesciences Holdings's total assets for Q2 2025 were $896.97M, a decrease of -6.54% from the previous quarter. MRVI total liabilities were $428.98M for the fiscal quarter, a -0.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.